Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rudin

Showing results (241-250 of 576) with videos related to

Pageof 58
Sort By:
Blood|November 4, 2008
Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cellsEsther Hulleman, Karin M Kazemier, Amy Holleman, et al.
Cancer Discovery|May 15, 2015
Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring MET mutations causing exon 14 skippingPaul K Paik, Alexander Drilon, Pang-Dian Fan, et al.
Nature Communications|January 14, 2018
Target engagement imaging of PARP inhibitors in small-cell lung cancerBrandon Carney, Susanne Kossatz, Benjamin H Lok, et al.
Molecular Cancer Therapeutics|August 28, 2020
Concurrent Targeting of Potential Cancer Stem Cells Regulating Pathways Sensitizes Lung Adenocarcinoma to Standard ChemotherapyMasahiro Shibata, Akira Ooki, Yoshikuni Inokawa, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2002
Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I studyPhilip C Hoffman, Ezra E W Cohen, Gregory A Masters, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2017
Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancersH A Yu, C Sima, D Feldman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 9, 2017
Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterationsNatasha Rekhtman, Catherine M Pietanza, Joshua Sabari, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 3, 2013
Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancerCharles M Rudin, Julie R Brahmer, Rosalyn A Juergens, et al.
STAR Protocols|October 31, 2022
Protocol to dissociate, process, and analyze the human lung tissue using single-cell RNA-seqÁlvaro Quintanal-Villalonga, Joseph M Chan, Ignas Masilionis, et al.
Journal of Medicinal Chemistry|September 1, 1995
Antidiabetic agents: a new class of reversible carnitine palmitoyltransferase I inhibitorsR C Anderson, M Balestra, P A Bell, et al.
Pageof 58

Showing results (241-250 of 576) with videos related to

Sort By:
Pageof 58
Blood|November 4, 2008
Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cellsEsther Hulleman, Karin M Kazemier, Amy Holleman, et al.
Cancer Discovery|May 15, 2015
Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring MET mutations causing exon 14 skippingPaul K Paik, Alexander Drilon, Pang-Dian Fan, et al.
Nature Communications|January 14, 2018
Target engagement imaging of PARP inhibitors in small-cell lung cancerBrandon Carney, Susanne Kossatz, Benjamin H Lok, et al.
Molecular Cancer Therapeutics|August 28, 2020
Concurrent Targeting of Potential Cancer Stem Cells Regulating Pathways Sensitizes Lung Adenocarcinoma to Standard ChemotherapyMasahiro Shibata, Akira Ooki, Yoshikuni Inokawa, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2002
Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I studyPhilip C Hoffman, Ezra E W Cohen, Gregory A Masters, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2017
Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancersH A Yu, C Sima, D Feldman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 9, 2017
Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterationsNatasha Rekhtman, Catherine M Pietanza, Joshua Sabari, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 3, 2013
Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancerCharles M Rudin, Julie R Brahmer, Rosalyn A Juergens, et al.
STAR Protocols|October 31, 2022
Protocol to dissociate, process, and analyze the human lung tissue using single-cell RNA-seqÁlvaro Quintanal-Villalonga, Joseph M Chan, Ignas Masilionis, et al.
Journal of Medicinal Chemistry|September 1, 1995
Antidiabetic agents: a new class of reversible carnitine palmitoyltransferase I inhibitorsR C Anderson, M Balestra, P A Bell, et al.
Pageof 58